• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Chest. Clinical Characteristics and Outcomes of Sepsis-Related vs Non-Sepsis-Related ARDS

Giuseppe

Emeritus
Clinical Characteristics and Outcomes of Sepsis-Related vs Non-Sepsis-Related ARDS (CHEST, abstract, edited)


[Source: Chest, full text: <cite cite="http://chestjournal.chestpubs.org/content/138/3/559.short?rss=1">Clinical Characteristics and Outcomes of Sepsis-Related vs Non-Sepsis-Related ARDS ? CHEST</cite>. Abstract, edited.]

Clinical Characteristics and Outcomes of Sepsis-Related vs Non-Sepsis-Related ARDS

1. Chau-Chyun Sheu, MD, 2. Michelle N. Gong, MD, 3. Rihong Zhai, MD, PhD, 4. Feng Chen, PhD, 5. Ednan K. Bajwa, MD, 6. Peter F. Clardy, MD, 7. Diana C. Gallagher, MD, 8. B. Taylor Thompson, MD and 9. David C. Christiani, MD, FCCP

Author Affiliations
1. From the Department of Environmental Health (Drs Sheu, Zhai, Chen, and Christiani), Harvard School of Public Health, Boston, MA; Pulmonary and Critical Care Unit (Drs Bajwa, Thompson, and Christiani), Department of Medicine, Massachusetts General Hospital, and the Division of Pulmonary, Critical Care, and Sleep Medicine (Drs Clardy and Gallagher), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Division of Critical Care Medicine (Dr Gong), Montefiore Medical Center, and Department of Epidemiology and Population Health (Dr Gong), Albert Einstein School of Medicine, Bronx, NY; and Division of Pulmonary and Critical Care Medicine (Dr Sheu), Kaohsiung Medical University Hospital, and Faculty of Respiratory Therapy (Dr Sheu), College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

1. Correspondence to: David C. Christiani, MD, FCCP, Department of Environmental Health, Harvard School of Public Health, 665 Huntington Ave, Room I-1401, Boston, MA 02115; e-mail: dchris@hsph.harvard.edu


Abstract

Background:
ARDS may occur after either septic or nonseptic injuries. Sepsis is the major cause of ARDS, but little is known about the differences between sepsis-related and non-sepsis-related ARDS.

Methods:
A total of 2,786 patients with ARDS-predisposing conditions were enrolled consecutively into a prospective cohort, of which 736 patients developed ARDS. We defined sepsis-related ARDS as ARDS developing in patients with sepsis and non-sepsis-related ARDS as ARDS developing after nonseptic injuries, such as trauma, aspiration, and multiple transfusions. Patients with both septic and nonseptic risks were excluded from analysis.

Results:
Compared with patients with non-sepsis-related ARDS (n = 62), patients with sepsis-related ARDS (n = 524) were more likely to be women and to have diabetes, less likely to have preceding surgery, and had longer pre-ICU hospital stays and higher APACHE III (Acute Physiology and Chronic Health Evaluation III) scores (median, 78 vs 65, P < .0001). There were no differences in lung injury score, blood pH, Pao2/Fio2 ratio, and Paco2 on ARDS diagnosis. However, patients with sepsis-related ARDS had significantly lower Pao2/Fio2 ratios than patients with non-sepsis-related ARDS patients on ARDS day 3 (P = .018), day 7 (P = .004), and day 14 (P = .004) (repeated-measures analysis, P = .011). Compared with patients with non-sepsis-related ARDS, those with sepsis-related had a higher 60-day mortality (38.2% vs 22.6%; P = .016), a lower successful extubation rate (53.6% vs 72.6%; P = .005), and fewer ICU-free days (P = .0001) and ventilator-free days (P = .003). In multivariate analysis, age, APACHE III score, liver cirrhosis, metastatic cancer, admission serum bilirubin and glucose levels, and treatment with activated protein C were independently associated with 60-day ARDS mortality. After adjustment, sepsis-related ARDS was no longer associated with higher 60-day mortality (hazard ratio, 1.26; 95% CI, 0.71-2.22).

Conclusion:
Sepsis-related ARDS has a higher overall disease severity, poorer recovery from lung injury, lower successful extubation rate, and higher mortality than non-sepsis-related ARDS. Worse clinical outcomes in sepsis-related ARDS appear to be driven by disease severity and comorbidities.


Footnotes
* Funding/Support: The work was supported by National Institutes of Health [Grants ES00002, HL60710, and HL087934].
* Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (http://www.chestpubs.org/site/misc/reprints.xhtml).
* Abbreviations ALI acute lung injury, APACHE Acute Physiology and Chronic Health Evaluation, APC activated protein C, GEE generalized estimating equation, HR hazard ratio, IQR interquartile range, LOS length of stay, PEEP positive end-expiratory pressure
* Received December 9, 2009.
* Accepted May 4, 2010.
* ? 2010 American College of Chest Physicians

-
-----
 
Back
Top Bottom